Rapid Reliable Simple
1,rapid and sensitive
Intended use:
The MultiSaliva Drugs of Abuse Rapid Test is a rapid visual immunoassay for the qualitative, presumptive detection of drugs of abuse in human oral fluid specimens. The test system consists of one or two membrane strips mounted in a plastic cassette.
This test detects combinations of the following drugs at the concentrations listed below. Specific combinations will vary according to the test in question:
Test Calibrator Cut-off (ng/mL)
Amphetamine (AMP) D-Amphetamine 50
Cocaine (COC) Benzoylecgonine 20
Marijuana (THC) 11-nor-Δ9-THC-9 COOH 12
Marijuana (THC) Δ9-THC 75
Methadone (MTD) Methadone 30
Methamphetamine (MET) D-Methamphetamine 50
Opiates (MOR) Morphine 40
Phencyclidine (PCP) Phencyclidine 10
EDDP(EDDP) 2-Ethyliden-1,5-Dimethyl-3,3-Diphenylpyrrolidine 20
Benzodiazepine (BZO) Oxazepam 10
Buprenorphine(BUP) Buprenorphine 5
Oxycodone(OXY) Oxycodone 40
Cotinine(COT) Cotinine 50
• The kit should be stored at 2-30°C until the expiry date printed on the sealed pouch.
• The test must remain in the sealed pouch until use.
• Do not freeze.
• Care should be taken to protect the components of the kit from contamination. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results.
Materials Provided:
• Individually packed tests
• Oral fluid swabs
• Package insert
• Workstation
• Package insert
• Specimen dispensers
Specimen: Saliva(human oral fluid specimens)
Certification:
CE
Principle:
The MultiSaliva Drugs of Abuse Rapid Test is an immunoassay based on the principle of competitive binding. Drugs that may be present in the oral fluid specimen compete against their respective drug conjugate for binding sites on their specific antibody.
During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug strip. The presence of drug above the cut-off concentration in the oral fluid specimen will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region.
A drug-positive oral fluid specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative oral fluid specimen will generate a line in the test line region because of the absence of drug competition. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.